IndraLab

Statements


SOCS1 inhibits USP18. 1 / 1
| 1

reach
"Defects in these negative regulators could lead to the over-activation of positive signal transduction, resulting in disease, such as SOCS1, which negatively regulates the lipopolysaccharide response XREF_BIBR, and USP18, down-regulates the IFN signaling pathway XREF_BIBR."